NCT04782453

Brief Summary

Tobacco use is associated with high mortality, and a range of morbidities including cancer, and lung and cardiovascular diseases. Furthermore, tobacco users who die prematurely deprive their families of income, raise the cost of health care and hinder economic development. India is the second-largest consumer (current use-48% males, 20% females; 275 million adults) and third largest producer of tobacco in the world5; and has one of the highest mortality related to tobacco. The treatment gap for tobacco use in India is as high as 92%. Opportunistic screening and brief interventions in primary care, although recommended by the World Health Organization (WHO), is largely missing in current practice in India. The existing tobacco cessation strategy in India has shown limited success due to poor availability and accessibility of tobacco cessation services, and non-availability of interventions that are culturally relevant and contextual to the target population. Preliminary formative research as a part of the larger ToQuit study has informed the development of the first version of the treatment package. This first version of the package was tested through a case series, by refining the intervention content and delivery mechanisms through an iterative process, to develop the final intervention. This pilot Randomised Control Trial (RCT) will aim to empirically evaluate the feasibility and acceptability of the mobile-based brief intervention (BI) for tobacco use, generate preliminary estimates of the impact of the BI, and fine-tune the procedures for a definitive RCT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
28 days until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2021

Completed
Last Updated

September 21, 2021

Status Verified

September 1, 2021

Enrollment Period

6 months

First QC Date

February 19, 2021

Last Update Submit

September 20, 2021

Conditions

Keywords

tobacco usesmokingsmokeless tobaccobrief interventionmobile messagingScreening, Brief Intervention and Referral to Treatment

Outcome Measures

Primary Outcomes (1)

  • Self-reported abstinence from tobacco in past 7 days preceding the outcome assessment

    After 3 months post-randomisation, all the participants will be asked if they used tobacco at least once in past 7 days.

    At 3 months post-randomisation in all participants regardless of treatment completion.

Secondary Outcomes (2)

  • Change in mean ASSIST score, from baseline to 3 months post-randomisation

    At baseline and at 3 months post-randomisation in all participants regardless of treatment completion.

  • Self-reported abstinence from tobacco in past 28 days preceding the outcome assessment

    At 3 months post-randomisation in all participants regardless of treatment completion.

Study Arms (2)

ToQuit

EXPERIMENTAL

Participants from the ToQuit intervention arm will receive the messages on their mobile phones for 8 weeks. The messages will be sent for 3-4 days a week.

Behavioral: ToQuit, a technology delivered tobacco cessation intervention

Control

OTHER

Participants from the control group will be sent the details of other functional tobacco helplines in India.

Behavioral: Tobacco quitting helplines

Interventions

The intervention messages will consist of specific content areas derived from the formative research of the study. Some of the components of the intervention include * Psychoeducation about consequences of tobacco use and benefits of quitting; * goal setting; * managing goals and self-monitoring of behavior; * avoidance strategies; * self-awareness and reflection messages; * social and pharmacological support, and help-seeking; * identifying and managing cravings; * relapse prevention strategies.

ToQuit

Participants from the control group will be sent the details of other functional tobacco helplines in India.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (\>18 years) current users of tobacco in any form. Current user will be defined as individuals who have used tobacco at least once in the past 28 days.
  • Willing to quit tobacco in next 2 months,
  • Having a personal mobile phone, and
  • Able to read and reply to short message service (SMS) text in English or Hindi

You may not qualify if:

  • Participants having a shared/family phone
  • Age \<18 years
  • Owns a mobile phone, but cannot read and reply to English or Hindi messages

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sangath Goa

Panjim, Goa, 403501, India

Location

MeSH Terms

Conditions

Tobacco UseSmoking

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Abhijit Nadkarni

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The PI and outcomes assessor will be masked. The screeners will recruit participants into the study, who will then be randomized to one of the two study arms. The data team will assign a masked outcome assessor to collect outcome data.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A parallel-arm individual randomized controlled trial, with a nested qualitative study. We will randomize participants in the intervention and control groups with 1:1 allocation ratio.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 19, 2021

First Posted

March 4, 2021

Study Start

April 1, 2021

Primary Completion

September 18, 2021

Study Completion

September 18, 2021

Last Updated

September 21, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations